Figure 4From: Thyroid function in children with growth hormone (GH) deficiency during the initial phase of GH replacement therapy - clinical implications IGF-I bioavailability (expressed as IGF-I/IGFBP-3 molar ratio) before and during rhGH therapy in particular subgroups of patients with respect to the initial diagnosis.Back to article page